$1.92 Billion is the total value of SABBY MANAGEMENT, LLC's 287 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACORDA THERAPEUTICS INC 1.75%note | $8,388,000 | -2.2% | 9,600,000 | 0.0% | 0.44% | +2.1% | ||
| EXELIXIS INCcall | $1,393,000 | +95.4% | 1,783 | 0.0% | 0.07% | +102.8% | ||
| VTVT | VTV THERAPEUTICS INCcl a | $811,000 | +12.5% | 139,747 | 0.0% | 0.04% | +16.7% | |
| INSMED INCput | $760,000 | -22.2% | 771 | 0.0% | 0.04% | -18.4% | ||
| AMARIN CORPORATION PLCput | $241,000 | +40.9% | 1,118 | 0.0% | 0.01% | +44.4% | ||
| HSGX | HISTOGENICS INC | $258,000 | -25.2% | 150,630 | 0.0% | 0.01% | -23.5% | |
| ZSAN | ZOSANO PHARMA INC | $170,000 | -42.6% | 128,600 | 0.0% | 0.01% | -40.0% | |
| ALLIQUA BIOMEDICAL INCcall | $54,000 | +35.0% | 483 | 0.0% | 0.00% | +50.0% | ||
| PROGENICS PHARMACEUTICALS INCput | $55,000 | -3.5% | 130 | 0.0% | 0.00% | 0.0% | ||
| NORTHWEST BIOTHERAPEUTICS INCput | $47,000 | -60.5% | 813 | 0.0% | 0.00% | -66.7% | ||
| RENNOVA HEALTH INC*w | $32,000 | -80.1% | 3,225,806 | 0.0% | 0.00% | -75.0% | ||
| INTELLIPHARMACEUTICS INTERNATIONAL INCput | $19,000 | -24.0% | 122 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.